Taibidi Pharmaceutical Technology(shijiazhuang) Co.,ltd.

This is the first time a new drug called TPD3310 is being tested in people. The study aims to find a safe dose and see if it can help control advanced solid tumors in patients who have no other effective treatments left. It will enroll adults with specific types of cancer, like l…